Press Release

Sheba Medical Center Partners with National Institutes of Health (NIH) to Establish New Pandemic Research Institute

Sheba Pandemic Research Institute (SPRI) to focus on multidisciplinary, collaborative infectious disease research and development of clinical products for emergency rapid deployment

RAMAT GAN, Israel – December 22, 2022Sheba Medical Center, Israel’s largest medical center and a Newsweek top-10 ranked world’s best hospital for the last four years, announced today a first-of-its-kind partnership with the U.S. government National Institutes of Health (NIH) to establish the new Sheba Pandemic Research Institute (SPRI). 

The institute will focus on multidisciplinary, multifaceted, and collaborative research, as well as translating global infectious diseases research into clinical products for rapid deployment in the event of future epidemics and pandemics. 

“The establishment of the Sheba Pandemic Research Institute represents a significant milestone in our ongoing efforts to prevent and combat future epidemics and pandemics,” said Prof. Gili Regev-Yochay, Director of the Sheba Pandemic Research Institute & Infectious Diseases Unit at Sheba Medical Center. “Together with the NIH, we hope that the discovery of pathogens and infectious diseases can be translated into health outcomes that not only improve but protect the lives of patients worldwide.” 

The establishment of the institute follows recent Sheba-led research published in New England Journal of Medicine demonstrating the necessity for mRNA Covid vaccine booster doses, and pinpointing the ideal timing for administering them. That research was based on a cohort of some 10,000 staff members at Sheba who have been part of an ongoing study measuring the efficacy of currently available Covid vaccines.

Working directly with the NIH Vaccine Research Center in Maryland, SPRI researchers will prioritize innovation in diagnosis of emerging pathogens and epidemiologic aimed at contributing to predictions of future viral and bacterial threats.

“The core of the National Institutes of Health and Vaccine Research Center mission is the application of scientific and technological knowledge to design and develop vaccines and biologics against infectious diseases” said Prof. Daniel Douek, Chief of the Human Immunology Section, Vaccine Research Center, NIH and newly appointed Senior Scientific Advisor of the Sheba Pandemic Research Institute. “Together with Sheba, we can turn discovery into real health advances.”

Alongside Prof. Douek, Dr. Abraham Mittelman, who was the Director of Management and Operation at the NIH Vaccine Research Center, will be appointed as an advisor for operations and management of the new institute.

About Sheba medical Center

The largest and most comprehensive medical center in the Middle East, Sheba Medical Center, Tel  Hashomer is generating global impact through its medical care, research and healthcare transformation.  Sheba’s City of Health boasts an acute-care hospital, rehabilitation hospital, research and innovation  hubs, medical simulation center and center for disaster response on one comprehensive campus in the  center of Israel. A university teaching hospital affiliated with the Sackler School of Medicine at Tel-Aviv  University, Sheba is shaping the future of healthcare, educating the next generation of care providers.  Sheba serves as a true hospital without borders, welcoming patients and healthcare professionals from  all over the world and consistently providing the highest-level medical care to all in need. Sheba has  been ranked a top-ten hospital in the world by Newsweek four years in a row (2019, 2020, 2021, 2022). 

For more information, visit: 

Media Contact: 

Phone: +972522330430
Email: [email protected]